{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T22:11:31Z","timestamp":1720995091608},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":654,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.jhep.2011.04.013","type":"journal-article","created":{"date-parts":[[2011,5,12]],"date-time":"2011-05-12T16:15:51Z","timestamp":1305216951000},"page":"939-940","source":"Crossref","is-referenced-by-count":12,"title":["New insights on the pathogenesis of biliary cirrhosis provided by studies in FXR knockout mice"],"prefix":"10.1016","volume":"55","author":[{"given":"Michel","family":"Fausther","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan A.","family":"Dranoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2011.04.013_b0005","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1476-5381.2008.00030.x","article-title":"Nuclear receptors as therapeutic targets in cholestatic liver diseases","volume":"156","author":"Zollner","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhep.2011.04.013_b0010","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/MOG.0b013e328324f87e","article-title":"Farnesoid X receptor agonists in biliary tract disease","volume":"25","author":"Fiorucci","year":"2009","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/j.jhep.2011.04.013_b0015","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1055\/s-0030-1253225","article-title":"Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis","volume":"30","author":"Wagner","year":"2010","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2011.04.013_b0020","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.gastro.2005.06.053","article-title":"Nuclear receptor ligands: rational and effective therapy for chronic cholestatic liver disease?","volume":"129","author":"Boyer","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.jhep.2011.04.013_b0025","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S0016-5085(03)01068-0","article-title":"Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice","volume":"125","author":"Wagner","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2011.04.013_b0030","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1053\/j.gastro.2004.08.001","article-title":"The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis","volume":"127","author":"Fiorucci","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2011.04.013_b0035","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/hep.23405","article-title":"Portal fibroblasts: underappreciated mediators of biliary fibrosis","volume":"51","author":"Dranoff","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2011.04.013_b0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.47.120505.105349","article-title":"The tangle of nuclear receptors that controls xenobiotic metabolism and transport: crosstalk and consequences","volume":"48","author":"Pascussi","year":"2008","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jhep.2011.04.013_b0045","series-title":"Molecular pathology of liver diseases","first-page":"467","article-title":"General and molecular principles of hepatobiliary pathology (Part IV): biliary cirrhosis","author":"Dranoff","year":"2011"},{"key":"10.1016\/j.jhep.2011.04.013_b0050","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/hep.20806","article-title":"VPAC1 expression is regulated by FXR agonists in the human gallbladder epithelium","volume":"42","author":"Chignard","year":"2005","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jhep.2011.04.013_b0055","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S1386-6346(03)00201-8","article-title":"Vectorial transport of bile acids in immortalized mouse bile duct cells","volume":"27","author":"Kida","year":"2003","journal-title":"Hepatol Res"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827811003588?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827811003588?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T20:59:52Z","timestamp":1543784392000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827811003588"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0168827811003588"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2011.04.013","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}